CCR5 blockade in rheumatoid arthritis: a randomised, double-blind, placebo-controlled clinical trial

Autor: Arno W R, van Kuijk, Clarissa E, Vergunst, Danielle M, Gerlag, Barry, Bresnihan, Juan J, Gomez-Reino, Regine, Rouzier, Patrick C, Verschueren, Christiaan, van der Leij, Christiaan, van de Leij, Mario, Maas, Maarten C, Kraan, Paul P, Tak

Publikováno v: Annals of the rheumatic diseases, 69(11), 2013-2016. BMJ Publishing Group
Annals of the Rheumatic Diseases, 69(11), 2013-2016. BMJ Publishing Group

ObjectiveC-C chemokine receptor type 5 (CCR5), a chemokine receptor expressed on T cells and macrophages, and its ligands are found in inflamed synovial tissue (ST) of patients with rheumatoid arthritis (RA). The rationale for testing CCR5 blockade i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4f659fb6371d2bdebd784751e24d679
https://doi.org/10.1136/ard.2010.131235